Dashboard
Manage Tickers

VXRTVaxart, Inc.


$ 0.89 $ 0.01 (1.21 %)    

Monday, 09-Sep-2024 15:59:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 0.8959
$ 0.89
$ 0.89 x 300
$ 0.90 x 300
$ 0.89 - $ 0.94
$ 0.52 - $ 1.54
1,794,313
na
203.76M
$ -0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vaxart-announces-preclinical-data-showing-its-mucosal-vaccine-technology-stimulates-immune-response-against-hpv-related-tumors-reduces-tumor-size-and-increases-survival-in-animal-model-indicating-potential-for-non-invasive-treatment-of-hpv-related-cervical-dysplasia
Vaxart Announces Preclinical Data Showing ...
08/28/2024 12:04:41

oral-vaccine-focused-penny-stock-vaxart-is-uniquely-positioned-analyst-sees-almost-83-upside
Oral Vaccine Focused Penny Stock Vaxart Is...
08/15/2024 17:57:40

Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vacci...

oppenheimer-initiates-coverage-on-vaxart-with-outperform-rating-announces-price-target-of-4
Oppenheimer Initiates Coverage On Vaxart w...
08/15/2024 09:31:20

Oppenheimer initiates coverage on Vaxart (NASDAQ:VXRT) with a Outperform rating and announces Price Target of $4.

1m-bet-on-this-penny-stock-check-out-these-4-stocks-under-2-insiders-are-aggressively-buying
$1M Bet On This Penny Stock? Check Out The...
06/21/2024 12:22:05

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/19/2024 16:30:59

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 16:31:11

vaxart-stock-is-moving-higher-after-the-bell-whats-going-on
Vaxart Stock Is Moving Higher After The Be...
06/17/2024 20:32:16

Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds ...

vaxart-provides-business-update-expects-net-proceeds-from-40m-offering-and-reimbursment-under-project-nextgen-award-of-up-to-453m-to-extend-cash-runaway-into-2026
Vaxart Provides Business Update; Expects N...
06/17/2024 20:08:10

— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 millio...

vaxart-bags-453m-worth-barda-funded-project-seeks-to-raise-40m-via-equity-offering
Vaxart Bags $453M Worth BARDA-Funded Proje...
06/14/2024 14:06:12

Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID...

why-adobe-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Adobe Shares Are Trading Higher By Aro...
06/14/2024 12:19:25

vaxart-shares-are-trading-higher-after-the-company-received-a-barda-funded-project-nextgen-award-valued-up-to-453-million-to-conduct-a-phase-2b-study-evaluating-its-covid-19-oral-pill-vaccine-candidate
Vaxart shares are trading higher after the...
06/14/2024 11:24:47

reported-earlier-vaxart-launches-40m-underwritten-offering-of-50m-common-stock-at-080share
Reported Earlier, Vaxart Launches $40M Und...
06/14/2024 06:50:03

Gross proceeds to Vaxart from the offering are expected to be $40 million, before deducting underwriting discounts and commissi...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/13/2024 20:31:04

vaxart-receives-up-to-453m-award-from-barda-for-phase-2b-study-of-oral-covid-19-vaccine
Vaxart Receives Up To $453M Award From BAR...
06/13/2024 20:16:20

Initial $65.7M For Study Start-Up; Remaining $387.2M Pending Further Study Approval; Enrollment Expected Summer 2024, Interim A...

palo-alto-networks-shares-drop-after-q3-results-in-line-guidance-the-details
Palo Alto Networks Shares Drop After Q3 Re...
05/20/2024 20:20:02

Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Q...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 12:06:42

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

vaxart-stock-climbs-after-blockbuster-q1-revenue
Vaxart Stock Climbs After Blockbuster Q1 R...
05/13/2024 20:29:57

Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in ...

vaxart-to-meet-with-fda-in-mid-2024-to-evaluate-clinical-data-and-discuss-next-steps-for-its-norovirus-program-anticipates-cash-runway-into-late-q4-of-2024
Vaxart To Meet With FDA In Mid-2024 To Eva...
05/13/2024 20:14:22

These data will inform potential next steps, such as potentially conducting a Phase 2b study and potentially a GII.4 challenge ...

vaxart-q1-2024-gaap-eps-014-inline-sales-2181m-beat-800000k-estimate
Vaxart Q1 2024 GAAP EPS $(0.14), Inline, S...
05/13/2024 20:11:16

Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. The company repo...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION